Patent US3595598A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4201712A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for preparation of 6-aryl-4H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepines

Assignee: Boehringer Ingelheim GmbH
•
Filing: 1977-03-31
•
Granted: 1980-05-06
•
Expires: 1997-03-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A multiple-step process for the preparation of 6-aryl-4H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepines of the formula <IMAGE> wherein R1 is hydrogen, halogen or lower alkyl of 1 to 2 carbon atoms; R2 is hydrogen, chlorine, bromine, straight or branched alkyl of 1 to 3 carbon atoms, omega -hydroxyalkyl of 1 to 3 carbon atoms, cycloalkyl of 3 to 6 carbon atoms or a 5- or 6-membered heterocycle comprising an oxygen sulfur or nitrogen atom, where the nitrogen atom may optionally be substituted by lower alkyl; and R3 is hydrogen, fluorine, chlorine, or bromine; and optionally acid addition salts thereof, starting from compounds of the formula <IMAGE> wherein R1 and R3 have the meanings defined above, and X is halogen, amino or acyloxy.

Inventors

  • 👤 Karl-Heinz Weber
  • 👤 Adolf Bauer
  • 👤 Adolf Langbein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 03:47
CPC Classifications
C; C07; C07D; C07D495/00; C07D495/02; C07D495/04; C07D333/00; C07D333/02; C07D333/04; C07D333/26; C07D333/30; C07D333/36; C07D495/12; C07D495/14

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 430 words
A process for the preparation of a 6-aryl-4 H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepine of the formula ##STR32## wherein R 1 is hydrogen, halogen or alkyl of 1 to 2 carbon atoms; R 2 is hydrogen, chlorine, bromine, straight or branched alkyl of 1 to 3 carbon atoms, ω-hydroxyalkyl of 1 to 3 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, tetrahydrofuranyl, tetrahydropyranyl, N-methyl-piperidyl or thienyl; and R 3 is hydrogen, fluorine, chlorine or bromine; which comprises the steps of (a) reducing a compound of the formula ##STR33## wherein R 1 and R 3 have the meanings defined above, and X is halogen, amino or carboxylic acyloxy, with sodium borohydride in dimethylformamide or dimethylacetamide at temperatures between 0° and +10° C. to form a corresponding carbinol of the formula ##STR34## wherein R 1 , R 3 and X have the meanings defined above; (b) treating the carbinol, optionally after conversion of the amino group into a halogen atom or after splitting off the acyl group, with a cyclization agent to form a carbonyl compound of the formula ##STR35## wherein R 1 and R 3 have the meanings defined above; (c) converting the carbonyl group into the mercapto, a lower alkoxy or an alkylmercapto group or into a halogen atom by conventional methods to form a compound of the formula ##STR36## wherein R 1 and R 3 have the meanings defined above, and X is Sh--, lower alkoxy, alkylmercapto or halogen; (d) reacting the compound thus obtained with a compound of the formula R.sub.2 --CO--NH--NH.sub.2 wherein R 2 has the meanings previously defined except chlorine and bromine; (e) optionally chlorinating or brominating a compound of the formula ##STR37## thus obtained, wherein R 1 and R 3 have the meanings defined above, with a chlorinating or brominating agent; (f) cleaving the oxazepine ring of the compound at the oxygen atom by treating it with a strong hydrohalic acid; (g) extracting the resulting hydrohalide of a compound of the formula ##STR38## wherein R 1 through R 3 have the meanings defined above and Hal 1 is halogen, with a water-immiscible solvent; (h) admixing the residue with a phosphorus halide or sulfur halide; (i) reacting the resulting dihalo compound of the formula ##STR39## wherein R 1 through R 3 have the meanings defined above, and Hal 1 and Hal 2 are halogen, with ammonia or an ammonia-releasing substance to form a compound of the formula ##STR40## wherein R 1 through R 3 have the meanings defined above; and (j) dehydrogenating the resulting compound with a halogen or a compound of the higher oxidation stage of chromium or manganese.
Claim 2
Dependent Claim 430 words
A process for the preparation of a 6-aryl-4 H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepine of the formula ##STR32## wherein R 1 is hydrogen, halogen or alkyl of 1 to 2 carbon atoms; R 2 is hydrogen, chlorine, bromine, straight or branched alkyl of 1 to 3 carbon atoms, ω-hydroxyalkyl of 1 to 3 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, tetrahydrofuranyl, tetrahydropyranyl, N-methyl-piperidyl or thienyl; and R 3 is hydrogen, fluorine, chlorine or bromine; which comprises the steps of (a) reducing a compound of the formula ##STR33## wherein R 1 and R 3 have the meanings defined above, and X is halogen, amino or carboxylic acyloxy, with sodium borohydride in dimethylformamide or dimethylacetamide at temperatures between 0° and +10° C. to form a corresponding carbinol of the formula ##STR34## wherein R 1 , R 3 and X have the meanings defined above; (b) treating the carbinol, optionally after conversion of the amino group into a halogen atom or after splitting off the acyl group, with a cyclization agent to form a carbonyl compound of the formula ##STR35## wherein R 1 and R 3 have the meanings defined above; (c) converting the carbonyl group into the mercapto, a lower alkoxy or an alkylmercapto group or into a halogen atom by conventional methods to form a compound of the formula ##STR36## wherein R 1 and R 3 have the meanings defined above, and X is Sh--, lower alkoxy, alkylmercapto or halogen; (d) reacting the compound thus obtained with a compound of the formula R.sub.2 --CO--NH--NH.sub.2 wherein R 2 has the meanings previously defined except chlorine and bromine; (e) optionally chlorinating or brominating a compound of the formula ##STR37## thus obtained, wherein R 1 and R 3 have the meanings defined above, with a chlorinating or brominating agent; (f) cleaving the oxazepine ring of the compound at the oxygen atom by treating it with a strong hydrohalic acid; (g) extracting the resulting hydrohalide of a compound of the formula ##STR38## wherein R 1 through R 3 have the meanings defined above and Hal 1 is halogen, with a water-immiscible solvent; (h) admixing the residue with a phosphorus halide or sulfur halide; (i) reacting the resulting dihalo compound of the formula ##STR39## wherein R 1 through R 3 have the meanings defined above, and Hal 1 and Hal 2 are halogen, with ammonia or an ammonia-releasing substance to form a compound of the formula ##STR40## wherein R 1 through R 3 have the meanings defined above; and (j) dehydrogenating the resulting compound with a halogen or a compound of the higher oxidation stage of chromium or manganese.
Claim 3
Dependent Claim 19 words
The process of claim 1, where the cyclization agent in step (b) is sodium isopropylate or sodium tert. butylate.
Claim 4
Dependent Claim 21 words
The process of claim 1, where the dehydrogenation in step (j) is carried out with a halogen as the dehydrogenation agent.
Claim 5
Dependent Claim 30 words
The process of claim 1, where the dehydrogenation in step (j) is carried out with a compound of the higher oxidation stages of chromium or manganese as the dehydrogenation agent.
Claim 6
Dependent Claim 14 words
The process of claim 4, wherein the dehydrogenation agent is an alkai metal dichromate.
Claim 7
Dependent Claim 14 words
The process of claim 4, where the dehydrogenation agent is an alkali metal permanganate.

References Cited (Backward Citations)

US3598808A Cited
US3904641A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-05-06 1983-11-05 1984-05-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-05-06 1987-11-05 1988-05-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-05-06 1991-11-05 1992-05-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag